Neurizon Therapeutics
€0.12
0
+€0+0% Wednesday 06:41
Statistics
Day High
0.12
Day Low
0.12
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ECQ0.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap1.99B
Macrogenics
MGNX
Mkt Cap220.15M
Karyopharm Therapeutics
KPTI
Mkt Cap94.78M
TG Therapeutics
TGTX
Mkt Cap3.64B
Array Technologies
ARRY
Mkt Cap1.02B
About
PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. PharmAust Limited was incorporated in 2000 and is based in Melbourne, Australia.
Show more...
CEO
Dr. Michael Thurn Ph.D.
Country
AU
ISIN
AU0000357261
WKN
000A40STF